Comparison of Karpasa Moola & Patra Churna in White discharge

Comparative Pharmacotherapeutic Evaluation of Karpasa (Gossypium herbaceum Linn.) Moola and Patra Churna in Shwetapradara

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/09/045608

Enrollment

Registered

2022-09-16

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N899- Noninflammatory disorder of vagina, unspecified Health Condition 2: N899- Noninflammatory disorder of vagina, unspecified Health Condition 3: N899- Noninflammatory disorder of vagina, unspecified Health Condition 4: N899- Noninflammatory disorder of vagina, unspecified Health Condition 5: N898- Other specified noninflammatory disorders of vagina Health Condition 6: N898- Other specified noninflammatory disorders of vagina Health Condition 7: N908- Other specified noninf

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Age between 18 to 45 years of female patients 2 Shwetasrava(Yonigata) 3 Yonikandu 4 Katishoola

Exclusion criteria

Exclusion criteria: 1 Per-vaginal white discharge due to Malignant condition,Cervicitis, cervical erosion & PID 2 Infection like STD 3 Planning for pregnancy 4 Pregnancy 5 Puerperium 6 Disease like DM etc.

Design outcomes

Primary

Measure	Time frame
Complete remission of the major symptoms i.e. Yonigata Shwetasrava (White vaginal discharge) and Yonikandu (vaginal itching)Timepoint: 4 Weeks	—

Secondary

Measure	Time frame
Relief in other symptoms like Katishoola (Low backache), Yonigata alpavedana (Mild vaginal pain), Daurbalya (Weakness)Timepoint: 4 Weeks	—

Countries

India

Contacts

Public ContactDr Sushma Rathod

Government Ayurved College and Hospital,Vadodara

kamals.ayu21c@gmail.com9909017823

Outcome results